Rezolute, Inc. - Common Stock (NV) (RZLT)
5.2500
+0.0400 (0.77%)
Rezolute Inc is a biopharmaceutical company focused on developing innovative therapies to address serious diseases and unmet medical needs, particularly in the fields of metabolic and ocular disorders
The company's research is aimed at advancing its proprietary drug candidates through clinical development to improve patient outcomes. By leveraging advanced scientific insights and novel technologies, Rezolute seeks to create impactful treatment options for conditions that currently have limited or no effective therapies, thereby contributing to the advancement of healthcare solutions.
Frequently Asked Questions
Is Rezolute, Inc. - Common Stock (NV) publicly traded?
Yes, Rezolute, Inc. - Common Stock (NV) is publicly traded.
What exchange does Rezolute, Inc. - Common Stock (NV) trade on?
Rezolute, Inc. - Common Stock (NV) trades on the Nasdaq Stock Market
What is the ticker symbol for Rezolute, Inc. - Common Stock (NV)?
The ticker symbol for Rezolute, Inc. - Common Stock (NV) is RZLT on the Nasdaq Stock Market
What is the current price of Rezolute, Inc. - Common Stock (NV)?
The current price of Rezolute, Inc. - Common Stock (NV) is 5.250
When was Rezolute, Inc. - Common Stock (NV) last traded?
The last trade of Rezolute, Inc. - Common Stock (NV) was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Rezolute, Inc. - Common Stock (NV)?
The market capitalization of Rezolute, Inc. - Common Stock (NV) is 304.20M
How many shares of Rezolute, Inc. - Common Stock (NV) are outstanding?
Rezolute, Inc. - Common Stock (NV) has 57.94M shares outstanding.